Preoperative survivin, ERCC1, and PTEN expression in stage III non-small cell lung cancer (NSCLC) patients (pts) treated with neoadjuvant and definitive chemoradiation and association with overall survival (OS)

被引：0
|
作者：
Batus, Marta [1 ]
Fidler, Mary J. [1 ]
Walters, Kelly Kaiser [1 ]
Pool, Mark [1 ]
Mahon, Brett [1 ]
Basu, Sanjib [1 ]
Borgia, Jeffrey Allen [1 ]
Sher, David [1 ]
Bonomi, Philip D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic Factors for Survival After Recurrence of Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy
    Sen, N.
    Bonomi, P.
    Fidler, M. J.
    Batus, M.
    Sher, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E434 - E434
  • [22] The Association of Immunotherapy With the Overall Survival of Inoperable Stage III Non-small Cell Lung Cancer Patients Who Do Not Receive Chemoradiation
    Amin, Saber A. A.
    Baine, Michael J. J.
    Rahman, Ibur
    Lin, Chi
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (01) : 14 - 21
  • [23] The ERCC1 C8092A polymorphism and grade III/IV gastrointestinal (GI) toxicity in non-small cell lung cancer (NSCLC) patients treated with chemoradiation.
    Suk, R
    Gurubhagavatula, S
    Park, S
    Zhou, W
    Su, L
    Lynch, TJ
    Wain, JC
    Neuberg, D
    Liu, G
    Christiani, DC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 130S - 130S
  • [24] Association of EGFR mutations with ERCC1 expression in non-small cell lung cancer.
    Liang, Wenhua
    Lin, Ziying
    Xu, Yutong
    Zhang, Yaxiong
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Long term survival of stage IIIB non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiation
    Mehmood, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane
    Huang, Cheng-Long
    Kadota, Kyuichi
    Liu, Dage
    Ueno, Masaki
    Nakasima, Nariyasu
    Ishikawa, Shinya
    Gotoh, Masashi
    Misaki, Noriyuki
    Chang, Sung-Soo
    Yokomise, Hiroyasu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (03) : 445 - 451
  • [27] Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer
    Shi, Zong-Hua
    Shi, Guang-Yong
    Liu, Lin-Gang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 3132 - 3137
  • [28] Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy
    Garg, Shalini
    Gielda, Benjamin T.
    Kiel, Krystyna
    Turian, Julius V.
    Fidler, Mary Jo
    Batus, Marta
    Bonomi, Philip
    Sher, David J.
    PRACTICAL RADIATION ONCOLOGY, 2014, 4 (05) : 342 - 348
  • [29] Association of PAK4 expression with overall survival in patients with non-small cell lung cancer (NSCLC).
    Mamdani, Hirva
    Wu, Sharon
    Morgan, Erin
    Khan, Husain Yar
    Nabhan, Chadi
    Nieva, Jorge J.
    Korn, Wolfgang Michael
    Uprety, Dipesh
    Puri, Sonam
    Khan, Hina
    Raez, Luis E.
    Borghaei, Hossein
    Halmos, Balasz
    Ma, Patrick C.
    Lopes, Gilberto
    Liu, Stephen V.
    Azmi, Asfar S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Prognostic and predictive role of ERCC1 protein expression in locally advanced stage III non-small cell lung cancer
    Lamiss Mohamed Sad
    Samar Galal Younis
    Mohamed Mosad Elity
    Medical Oncology, 2014, 31
12345